Delivery Order SPE2DB20D1110-SPE2DB25FK46L
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML in pen/milliliter format, with a contract ceiling value of $20,981.41. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $134,643.50 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen medication. This firm fixed price delivery order, issued on September 9, 2025, with completion scheduled for September 10, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a $63,561.98 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/mL, a pharmaceutical product for federal medical supply needs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $55,373.90 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml in pen format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,788.01 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,222.60 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $51,415 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication with a completion date of September 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,255.41 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order valued at $107,385.45 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml, a specialty pharmaceutical product. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $19,725.93 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide SKYRIZI 150 MG/ML PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK46LDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,815.97 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen/ml pharmaceutical product. This firm fixed price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.8k | 9/26/25 |